drugset / Trial / NCT07349680

Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia

NCT07349680

Phase 3 Completed 100 enrolled Assiut University
RandomizedParallel-groupSingle-blindTreatment

Summary

Background: Acute herpes zoster causes severe neuropathic pain and may progress to postherpetic neuralgia (PHN). This study aims to evaluate ultrasound-guided thoracic paravertebral block with local anesthetic and steroid in reducing acute pain and PHN incidence. Methods: This prospective randomized study included 100 patients diagnosed with acute thoracic herpes zoster (rash ≤14 days, NRS ≥4). Participants were allocated into two groups: a control group receiving standard medical treatment and an intervention group receiving standard treatment in addition to an ultrasound-guided thoracic paravertebral block with (0.25% bupivacaine + 40 mg methylprednisolone) at 48-72-hour intervals. Pain intensity was assessed at baseline and during follow-up. The incidence of postherpetic neuralgia was recorded. Secondary outcomes included analgesic consumption and patient satisfaction.

Timeline

Start
2023-03-15
Primary completion
2025-09-20
Completion
2025-10-10

Drugs

EvaluationDrugModalityDoseRoute
Background Acetaminophen Small molecule 1 g Oral
Background Gabapentin Small molecule 1800 mg Oral
Background Valacyclovir Unknown 1000 mg Oral